Both in Pharmaceuticals
Travere Therapeutics vs Definium Therapeutics
Over the past year TVTX returned +84.5% and DFTX returned +111.1%; their daily moves had a correlation of 0.24.
TVTX +84.5% DFTX +111.1%Growth of $1, one year, split-adjusted
| Metric | TVTX | DFTX |
|---|---|---|
| Price | $52.40 | $32.47 |
| Market cap | $4.94B | $4.36B |
| Today | +6.04% | −2.81% |
| 1 month | −6.4% | −8.8% |
| 6 months | +17.1% | +38.6% |
| Year to date | +37.1% | — |
| 1 year | +51.7% | — |
| Revenue growth (YoY) | +36.2% | — |
| Gross margin | 98.7% | — |
| Net margin | −23.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.6× | — |
| Net cash | -$131.7M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 57.0% |
| Short % of float | 12.1% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).